# Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients

> **NCT01889290** · PHASE1 · COMPLETED · sponsor: **University of Zurich** · enrollment: 9 (actual)

## Conditions studied

- Opioid Use, Unspecified With Other Opioid-induced Disorder

## Interventions

- **DRUG:** Methylnaltrexone

## Key facts

- **NCT ID:** NCT01889290
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2016-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01889290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01889290, "Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01889290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*